BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Altor BioScience Corporation In-Licenses Tissue Factor Antagonists from Genentech, Inc.

  February 12, 2008

   · 

  1 min read
• Business

  ACADIA Pharmaceuticals, Inc. Appoints John J. Kaiser as Vice President, Strategic Marketing and Commercial Development

  February 12, 2008

   · 

  1 min read
• Drug Development

  Biovitrum AB Has Completed an Exploratory Clinical Phase II Study in Glaucoma

  February 12, 2008

   · 

  3 min read
• Genetown

  Infinity Pharmaceuticals, Inc. to Present At Annual Roth OC Growth Stock Conference

  February 12, 2008

   · 

  1 min read
• Drug Development

  Depomed, Inc. Reports Positive Efficacy Data From a Phase 2 Trial of Gabapentin GR(TM) in the Treatment of Menopausal Hot Flashes

  February 12, 2008

   · 

  8 min read
• Drug Development

  Raven Biotechnologies, Inc. to Provide Updates on Oncology Pipeline With Four AACR Presentations

  February 12, 2008

   · 

  2 min read
• Business

  Mersana Therapeutics, Inc. Appoints Chief Scientific Officer

  February 12, 2008

   · 

  2 min read
• Business

  Cell Therapeutics, Inc. Projects Zevalin(R) Sales of $15 Million

  February 12, 2008

   · 

  7 min read
• Drug Development

  Peregrine Pharmaceuticals, Inc. Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer

  February 12, 2008

   · 

  5 min read
• Drug Development

  AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers

  February 12, 2008

   · 

  5 min read